The Research & Experimentation (R&D) Tax Credit is one of the most powerful and underutilized tax incentives available to U.S. businesses.
Each year, the federal government allocates over $12 billion to fuel innovation, yet less than 1 in 3 eligible companies take advantage of it.
Why? Misconceptions, confusion, and now… a big rule change.
🔥 New Rule Alert: Capitalizing R&D Costs 🔥
Starting in 2022, Section 174 now requires businesses to capitalize and amortize their R&D costs over:
📌 5 years for U.S.-based research
📌 15 years for foreign-based research
This means businesses can no longer immediately deduct R&D expenses in the year they’re incurred.
Instead, they must spread the cost over time—impacting cash flow and tax liability in the short term.
However, the R&D tax credit still offers a direct dollar-for-dollar tax reduction, making it a crucial tool to offset these changes.
Busting Common R&D Credit Myths 🧐
❌ Myth: “We’re not profitable, so the credit doesn’t help.”
✅ Truth: Startups can use the credit to offset up to $500K in payroll taxes each year!
❌ Myth: “Only tech and pharma companies qualify.”
✅ Truth: If you’re improving a product, process, or software in manufacturing, construction, food & beverage, or other industries, you may qualify.
❌ Myth: “Our research isn’t groundbreaking.”
✅ Truth: You don’t need to reinvent the wheel. Even refining a process or testing new methods counts!
What Can You Claim? 💰
💼 Wages: Employees engaged in R&D activities
🛠 Supplies: Materials used in research
🤝 Contract Research: 65% of U.S.-based R&D contractors
💻 Cloud & Computing Costs: Used for R&D purposes
The Bottom Line?
Yes, the new capitalization rule is a challenge—but the R&D tax credit is more valuable than ever.
If your business is investing in innovation, you owe it to yourself to explore this credit.
📩 Want to see if you qualify?
Let’s chat. 🚀
Contact Us Today!